| 000 | 01583 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518013044.0 | ||
| 264 | 0 | _c20200120 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155218816776 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAyesh Haj Yousef, Mahmoud H | |
| 245 | 0 | 0 |
_aVinblastine-induced posterior reversible encephalopathy syndrome. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cDec 2019 |
||
| 300 |
_a2019-2022 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPosterior Leukoencephalopathy Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 700 | 1 | _aEyadeh, Ahmed | |
| 700 | 1 | _aRawashdeh, Rand Al | |
| 700 | 1 | _aKhasawneh, Ruba | |
| 700 | 1 | _aSaleh, Judy A | |
| 700 | 1 | _aJibreel, Malak J | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 25 _gno. 8 _gp. 2019-2022 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155218816776 _zAvailable from publisher's website |
| 999 |
_c29151068 _d29151068 |
||